With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Single-Cell Profiling of Acute Myeloid Leukemia for High-Resolution Chemo-immunotherapy Target Discovery||Stanford University School of Medicine / Charles Gawad, MD/PhD||Single-cell Pediatric Cancer Atlas Grant||2019||California|
|Profiling the Transcriptional Heterogeneity of Diverse Pediatric Solid Tumors||St. Jude Children's Research Hospital / Michael Dyer, PhD and Xiang Chen, PhD||Single-cell Pediatric Cancer Atlas Grant||2019||Tennessee|
|Single-cell Atlas of Pediatric Osteosarcoma||Dana-Farber Cancer Institute / Natalie Collins, MD/PhD||Single-cell Pediatric Cancer Atlas Grant||2019||Massachusetts|
|Single-cell Gene Expression and Cytosine Modification Profiling in Pediatric Central Nervous System Tumors||Dartmouth College / Brock Christensen, PhD||Single-cell Pediatric Cancer Atlas Grant||2019||New Hampshire|
|Synergistic Activity of Anti-GD2 Antibody and CD47-Blockade for Immunotherapy of Neuroblastoma and Osteosarcoma||The Board of Trustees of the Leland Stanford Junior University / Robbie Majzner, MD||'A' Award Grants||2019||California|
|Elucidating the Role of SETD2 in Pediatric High Grade Glioma Formation||Children's Hospital of Philadelphia / Thomas De Raedt, PhD||'A' Award Grants||2019||Pennsylvania|
|Exploiting the Differentiation Potential of Pediatric High-Grade Glioma to Discover Novel Therapeutic Opportunities||Dana-Farber Cancer Institute / Mariella Filbin, MD/PhD||'A' Award Grants||2019||Massachusetts|
|The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade||University of Florida / Catherine Flores, PhD||Innovation Grants||2019||Florida|
|Identify Novel Druggable Targets to Treat Philadelphia chromosome-like B-Acute Lymphoblastic Leukemia||Children's Hospital of Philadelphia / Wei Tong, PhD||Innovation Grants||2019||Pennsylvania|
|Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy||Research Institute at Nationwide Children's Hospital / Dawn Chandler, PhD||Innovation Grants||2019||Ohio|